CD44 and hepatocellular carcinoma: With aberrant DNA hypermethylation due to low expression of DNMT1, the expressions of some tumor suppressors, involving genes aberrantly methylated in HCC and those as drivers of other cancers, were significantly up-regulated, which could break down the balance of self-renewal and differentiation of CD133+/CD44+ cells.